Evidence map›Paper›PMID 40365456›Full record

ArticleFrontiers in neurology2025

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study.

Miguel Ángel Robles-Sánchez, Paloma Amil-Bujan, Cristina Bosch-Farré, Clàudia Coll-Martínez, María Jesús Arévalo, Elisenda Anglada-Clofent, Rebeca Menéndez-Díaz, Montserrat Aroca-Alsina, Miguel Merchan-Ruiz, Santiago Pérez-Hoyos and 14 more

Registry-linked trialAbstract read
In one paragraph

Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04988880 (Territorial Implementation and Evaluation of an Expert Patient Program to Improve the Empowerment and Quality of Life of People With Multiple Sclerosis), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04988880 nacompletednot on this map

Territorial Implementation and Evaluation of an Expert Patient Program to Improve the Empowerment and Quality of Life of People With Multiple Sclerosis

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2021 to 2024Enrolled152ConditionsMultiple Sclerosis, Quality of Life, Patient Empowerment, Patient ActivationArmsMultiple Sclerosis Expert Patient Program of Catalonia
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Miguel Ángel Robles-SánchezDepartment of Nursing, Health and Health Care Research Group, University of Girona, Girona, Spain.
Paloma Amil-BujanExpert Patient Programme Catalonia, Integrated Care Strategy, General Directorate for Health Planning, Department of Health, Generalitat de Catalunya, Barcelona, Spain.
Cristina Bosch-FarréDepartment of Nursing, Health and Health Care Research Group, University of Girona, Girona, Spain.
Clàudia Coll-MartínezGirona Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.
María Jesús ArévaloDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Elisenda Anglada-ClofentDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Rebeca Menéndez-DíazDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Montserrat Aroca-AlsinaDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Miguel Merchan-RuizGirona Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.
Santiago Pérez-HoyosStatistics and Bioinformatics Unit (UEB), Vall d'Hebron Recerca Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ángel Guillermo Arévalo-BernabéDepartment of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
Xavier MontalbanDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Ana HernandoMS-Neuroimmunology Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Sara LLufriúMS-Neuroimmunology Unit and Laboratory of Advanced Imaging in Neuroimmunological Diseases (ImaginEM), Hospital Clinic Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Silvia Peralta-MoncusíDepartment of Neurology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida-IRBLleida, Lleida, Spain.
Lluís BrievaDepartment of Neurology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida-IRBLleida, Lleida, Spain.
Cristina Ramo-TelloNeurologist MS Unit, Hospital Germans Trias i Pujol, Badalona, Spain.
Mariona CarabíNurse MS Unit, Hospital Germans Trias i Pujol, Badalona, Spain.
Nuria Solà-VallsHospital Universitari Sant Joan de Reus, Clinical and Epidemiological Neuroscience Group (NeuroÈpia), Institut d' Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Maria Cinta ZabayDepartment of Nursing, Centro Neurorehabilitador Mas Sabater, Fundació Esclerosi Múltiple, Reus, Spain.
Maria Alba Mañé-MartínezDepartment of Neurology, Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Jaume Sastre-GarrigaDepartment of Neurology, Centre d'Esclerosi Múltiple de Catalunya (Cemcat), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Lluís Ramió-TorrentàGirona Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Dr. Josep Trueta University Hospital and Santa Caterina Hospital, Girona, Spain.
Carmen Bertran-NoguerDepartment of Nursing, Health and Health Care Research Group, University of Girona, Girona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis (MS) is associated with complex needs and demands, which require patient-centered care. Expert patient (EP) programs foster knowledge transfer through peer learning, facilitating patients' empowerment to self-manage their disease. Based on a previous focus group study, we designed an EP program for MS coordinated by nursing professionals for implementation in the different MS reference units of Catalonia (Southwestern Europe). This study aimed to deploy a nurse-led Expert Patient Program of Catalonia™ (EPPC) for people with MS and evaluate its impact on disease-related knowledge, empowerment, and health indicators. Methods: Pre-test, post-test interventional, multicenter study conducted between January 2021 and December 2023 (NCT NCT04988880). Six MS teams recruited 12 groups of people with relapsing and progressive MS. Participants attended nine virtual sessions led by an EP, trained and supported by a nurse. Questionnaires were delivered after certain sessions and at 6 and 12 months. Results: Fifty-five participants with relapsing disease and 57 with progressive disease received the intervention. Nine of 18 knowledge questions showed significantly higher post-test vs. pre-test correct answers. Hospital Anxiety and Depression Scale remained unchanged for anxiety and transiently increased for depression, whereas the Patient Activation Measure-13 increased at 12 months, by mean (SD) 2.04 [5.88] points (

Indexed as

disability statusdisease-related knowledgeempowermentexpert patient programlifestyle habitsmultiple sclerosisnursing-led interventionquality of life

Identifiers

PMID40365456
PMCPMC12071084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.